Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>Delirium is the most common postoperative neurological complication and some evidence suggests that dexmedetomidine is associated with a decreased incidence of delirium. This study is designed to assess the effect of dexmedetomidine on postoperative delirium (POD) in elderly patients with mild cognitive impairment (MCI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Sixty geriatric patients with MCI were enrolled and ramdomly divided into two groups by a computer‐generated randomisation sequence: dexmedetomidine group (D group) and normal saline group (C group). Patients in D group received a loading dose of 0.5 μg/kg dexmedetomidine over 10 minutes before anesthesia induction, followed by a continuous infusion of 0.4 μg·kg<sup>‐1</sup>·h<sup>‐1</sup> until 30 min before the end of surgery; equal volume of normal saline was given in C group. Blood samples were extracted to detect the concentration of cytokines, including TNF‐α, IL‐10, HO‐1, matrix metalloproteinase‐9 (MMP‐9) and glial fibrillary acidic protein (GFAP) before anesthesia induction (T<sub>1</sub>), before suture (T<sub>2</sub>), and 30 min after surgery (T<sub>3</sub>). Postoperative recovery times were recorded. Delirium was assessed with the 3‐Minute Diagnostic Interview for confusion assessment method during the first 7 days postoperatively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>POD occurred in 10 (33.3%) of 30 patients in C group, and in 3 (10%) of 30 patients given dexmedetomidine (odds ratio [OR] 0.222, 95% CI 0.054–0.914; <i>P</i>=0.028). The serum concentrations of TNF‐α, MMP‐9, and GFAP were significantly increased and IL‐10 was decreased in the C group than in the D group at T<sub>2</sub> and T<sub>3</sub>. No differences were observed between groups in the level of HO‐1. Analysis using random‐effect multivariable logistic regression indicated that POD was associated with GFAP (odds ratio [OR] 16.691, 95% CI 2.288–121.746; <i>P</i>=0.005). The positive predictive ability of the multivariate logistic regression model tested by ROC analysis showed an area under the curve of 0.713 (95% CI, 0.584–0.842). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Dexmedetomidine can alleviate POD in elderly patients with MCI and may be related to reduce the neuroinflammation by lowering the permeability of blood‐brain barrier.</p><p>This article is protected by copyright. All rights reserved.</p></section>

Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis

Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction in Aged Mice

Dexmedetomidine ameliorates postoperative cognitive dysfunction by inhibiting Toll‐like receptor 4 signaling in aged mice

Both PI3K/Akt and ERK1/2 Pathways Participate in the Protection by Dexmedetomidine Against Transient Focal Cerebral Ischemia/reperfusion Injury in Rats

Dexmedetomidine-mediated improvement of perioperative neurocognitive disorders by miR-184-3p-mediated NLRP3

Effects of dexmedetomidine on cognitive dysfunction and neuroinflammation via the HDAC2/HIF‐1α/PFKFB3 axis in a murine model of postoperative cognitive dysfunction

Effects of dexmedetomidine on postoperative cognitive function of sleep deprivation rats based on changes in inflammatory response

Dexmedetomidine alleviates postoperative cognitive dysfunction through circular RNA in aged rats

Exploring the Potential Role of Dexmedetomidine in Reducing Postoperative Cognitive Dysfunction in Elderly Hip Fracture Patients

Dexmedetomidine mitigates neuroinflammation and improves early postoperative neurocognitive dysfunction in rats by enhancing autophagy

Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment

Study on the Effect of Dexmedetomidine on Postoperative Cognitive Dysfunction and Inflammation in Aged Rats

Dexmedetomidine Mitigates Microglial Activation Associated with Postoperative Cognitive Dysfunction by Modulating the MicroRNA-103a-3p/VAMP1 Axis

Dexmedetomidine Might Improve Postoperative Cognitive Dysfunction in Older Patients Undergoing Pulmonary Surgery

Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System

Dexmedetomidine attenuates postoperative spatial memory impairment after surgery by reducing cytochrome C

Effects of dexmedetomidine on renal function, inflammatory markers, and cognitive functioning in elderly patients undergoing hip replacement surgery

Dexmedetomidine Reverses Postoperative Spatial Memory Deficit by Targeting Surf1 and Cytochrome c

Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery

Dexmedetomidine alleviates cognitive impairment by reducing blood-brain barrier interruption and neuroinflammation via regulating Th1/Th2/Th17 polarization in an experimental sepsis model of mice

Impact of intraoperative dexmedetomidine on postoperative delirium and pro-inflammatory cytokine levels in elderly patients undergoing thoracolumbar compression fracture surgery: A prospective, randomized, placebo-controlled clinical trial